数据表1:人工智能在糖尿病视网膜病变筛查中的应用——沙特阿拉伯视角

沙特阿拉伯眼科专业人员对AI用于糖尿病视网膜病变筛查认知与接受度的论文补充数据表(docx文档)。

NIAID Data Ecosystem
浏览 15
文本diabetic retinopathyartificial intelligencescreeningSaudi ArabiaophthalmologyCOVID-19pandemic
Data_Sheet_1_The application of artificial intelligence in diabetic retinopathy screening: a Saudi Arabian perspective.docx

基本信息

模态
文本
大小
0.000042743 GB
许可
CC BY 4.0
创建/更新时间
2026-10-17
版本
v1

资源简介

数据表1:人工智能在糖尿病视网膜病变筛查中的应用——沙特阿拉伯视角

【一句话概览】

本数据集是 figshare 公开的文本数据集,收录 1 个文件、合计 42.74 KB,主题涵盖 diabetic retinopathy、artificial intelligence、screening、Saudi Arabia、ophthalmology,可用于医学自然语言处理(实体识别、信息抽取等),CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Data_Sheet_1_The application of artificial intelligence in diabetic retinopathy screening: a Saudi Arabian perspective.docx》。配套论文《<p>The Evolution of Diabetic Retinopathy Screening Programmes: A Chronology of Retinal Photography from 35 mm Slides to Artificial Intelligence</p>》发表于 Clinical Ophthalmology(2020),DOI:10.2147/OPTH.S261629。源站首次发布:2023-11-23。

【数据内容】

源站原始描述:IntroductionDiabetic retinopathy (DR) is the leading cause of preventable blindness in Saudi Arabia. With a prevalence of up to 40% of patients with diabetes, DR constitutes a significant public health burden on the country. Saudi Arabia has not yet established a national screening program for DR. Mounting evidence shows that Artificial intelligence (AI)-based DR screening programs are slowly becoming superior to traditional screening, with the COVID-19 pandemic accelerating research into this t…

【数据结构与技术规格】

文件数 1 个,合计 42.74 KB。Data_Sheet_1_The application of artificial intelligence in diabetic retinopathy screening: a Saudi Arabian perspective.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,42.74 KB。数据集 DOI:10.3389/fmed.2023.1303300.s001。

【主题与分类】

源站学科分类:Radiology and Organ Imaging、Foetal Development and Medicine、Obstetrics and Gynaecology、Primary Health Care、Medical and Health Sciences not elsewhere classified、Dermatology。主题标签:diabetic retinopathy、artificial intelligence、screening、Saudi Arabia、ophthalmology、COVID-19、pandemic。

【适用方向】

文本类数据可用于医学自然语言处理,如命名实体识别、信息抽取与文本分类。

【获取与许可】

源站页面:https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_The_application_of_artificial_intelligence_in_diabetic_retinopathy_screening_a_Saudi_Arabian_perspective_docx/24618750

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Barakat, Abdulaziz A.; Mobarak, Omar; Javaid, Haroon Ahmed; Awad, Mhd Rasheed; Hamweyah, Karam; Ouban, Abderrahman; et al. (2023). Data_Sheet_1_The application of artificial intelligence in diabetic retinopathy screening: a Saudi Arabian perspective.docx. Frontiers. Dataset

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "Data_Sheet_1_The application of artificial intelligence in diabetic retinopathy screening: a Saudi Arabian perspective.docx" "https://ndownloader.figshare.com/files/43259058"

文件清单

  • Data_Sheet_1_The application of artificial intelligence in diabetic retinopathy screening: a Saudi Arabian perspective.docx(42.74 KB)

文件总体积 42.74 KB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

IntroductionDiabetic retinopathy (DR) is the leading cause of preventable blindness in Saudi Arabia. With a prevalence of up to 40% of patients with diabetes, DR constitutes a significant public health burden on the country. Saudi Arabia has not yet established a national screening program for DR. Mounting evidence shows that Artificial intelligence (AI)-based DR screening programs are slowly becoming superior to traditional screening, with the COVID-19 pandemic accelerating research into this topic as well as changing the outlook of the public toward it. The main objective of this study is to evaluate the perception and acceptance of AI in DR screening among eye care professionals in Saudi Arabia.
MethodsA cross-sectional study using a self-administered online-based questionnaire was distributed by email through the registry of the Saudi Commission For Health Specialties (SCFHS). 309 ophthalmologists and physicians involved in diabetic eye care in Saudi Arabia participated in the study. Data analysis was done by SPSS, and a value of p 54% of participants rated their level of AI knowledge as above average and 63% believed that AI and telemedicine are interchangeable. 66% believed that AI would decrease the workforce of physicians. 79% expected clinical efficiency to increase with AI. Around 50% of participants expected AI to be implemented in the next 5 years.
DiscussionMost participants reported good knowledge about AI. Physicians with more clinical experience and those who used e-health apps in clinical practice regarded their AI knowledge as higher than their peers. Perceived knowledge was strongly related to acceptance of the benefits of AI-based DR screening. In general, there was a positive attitude toward AI-based DR screening. However, concerns related to the labor market and data confidentiality were evident. There should be further education and awareness about the topic.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fmed.2023.1303300.s001(source: https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_The_application_of_artificial_intelligence_in_diabetic_retinopathy_screening_a_Saudi_Arabian_perspective_docx/24618750)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案